Related Experiment Videos
Dehydroepiandrosterone enhances influenza immunization in aged mice
H D Danenberg1, A Ben-Yehuda, Z Zakay-Rones
1Division of Medicine, Hadassah University Hospital, Jerusalem, Israel.
Annals of the New York Academy of Sciences
|December 29, 1995
Summary
Dehydroepiandrosterone (DHEA) treatment improved immune response in older mice against the influenza vaccine. DHEA administration enhanced antibody production and resistance to viral challenge, counteracting age-related immune decline.
Area of Science:
- Immunology
- Gerontology
- Vaccinology
Background:
- Aging is associated with a decline in immune function, impacting vaccine efficacy.
- Influenza remains a significant public health concern, particularly for the elderly population.
- Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone with potential immunomodulatory effects.
Purpose of the Study:
- To investigate the effect of DHEA administration on age-associated immune decline against influenza.
- To evaluate DHEA's impact on humoral immune response and resistance to influenza virus post-vaccination in aged mice.
Main Methods:
- Aged mice (16- and 24-month-old) were treated with DHEA.
- Mice were immunized with live A/PR/8/34 (H1N1) influenza virus.
- Humoral response and resistance to post-vaccination intranasal challenge were assessed.
Main Results:
- DHEA treatment led to an increased humoral immune response in aged mice immunized with influenza virus.
- DHEA-treated mice showed enhanced resistance to intranasal challenge with live influenza virus after vaccination.
- The study observed a significant improvement in immune function in aged mice following DHEA administration.
Conclusions:
- DHEA administration can effectively overcome age-related defects in immunity against influenza.
- DHEA holds potential as an adjunct therapy to enhance vaccine efficacy in aging populations.
- Further research into DHEA's immunomodulatory mechanisms is warranted.